Mark Wingertzahn
Direttore Tecnico/Scientifico/R&S presso WESANA HEALTH HOLDINGS INC.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Daniel Carcillo | M | - | - | |
| Kevin Silva | M | 70 |
New York Institute of Technology
| 17 anni |
| Charlene DeGregoria | F | - |
New York Institute of Technology
| 14 anni |
| George Michael Steinbrenner | M | 27 | - | |
| Mitchell Kahn | M | 63 | - | |
| Charanjit Bountra | M | 63 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | - |
| Santhosh Keshavan | M | 50 |
New York Institute of Technology
| - |
| Ian Burnstein | M | 54 | 3 anni | |
| Xian Fang Liu | M | 71 |
New York Institute of Technology
| 27 anni |
| Tom Bianculli | M | - |
New York Institute of Technology
| - |
| Peter A. Ferentinos | M | - |
New York Institute of Technology
| - |
| Paul Lirette | M | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 36 anni |
| Alan Guarino | M | 64 |
New York Institute of Technology
| - |
| Yong Biao Ding | M | - | 1 anni | |
| Ken Batchelor | M | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | - |
| Robert Evanson | M | 87 |
New York Institute of Technology
| - |
| Melissa Karp Smith | F | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | - |
| V. Michael Mavaddat | M | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | - |
| Philip Fasano | M | 65 |
New York Institute of Technology
| - |
| Andrew Witty | M | 59 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | - |
| Michael J. Merlo | M | 76 |
New York Institute of Technology
| - |
| Ruth Kemp | F | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | - |
| Lee S. Simonson | M | 75 |
New York Institute of Technology
| 22 anni |
| Christopher Gent | M | 75 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | - |
| Rich Daly | M | 71 |
New York Institute of Technology
| - |
| Monte N. Redman | M | 72 |
New York Institute of Technology
| - |
| Alexander Kaganowicz | M | 77 |
New York Institute of Technology
| - |
| Cristina L. Mendoza | F | 77 |
New York Institute of Technology
| - |
| Jun Ma | M | 60 |
New York Institute of Technology
| 31 anni |
| Robert Koffman | M | - | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 22 | 73.33% |
| Canada | 8 | 26.67% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Mark Wingertzahn
- Contatti personali
